Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Not Applicable
Completed
- Conditions
- Refractive ErrorPresbyopiaMyopiaHyperopiaAstigmatism
- Interventions
- Device: Lotrafilcon B contact lensesDevice: Senofilcon A contact lensesDevice: Habitual Multi-Purpose Solution (MPS)Device: OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS)
- Registration Number
- NCT01809197
- Lead Sponsor
- Alcon Research
- Brief Summary
The purpose of this study was to compare lens comfort on Day 30 for Air Optix® lenses cared for with OPTI-FREE® PureMoist® (OFPM) Multi Purpose Disinfecting Solution (MPDS) compared to Acuvue® Oasys® lenses cared for with habitual MPDS.
- Detailed Description
Prior to the 30-day study period, subjects were fitted with study lenses in a masked manner and underwent a run-in period of 4-8 days to adjust to the randomized lenses.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 387
Inclusion Criteria
- Sign informed consent.
- Currently wearing weekly/monthly contact lenses on a daily wear basis, as specified in protocol.
- Willing to wear contact lenses on a daily wear basis for the duration of the study.
- Currently using a multi-purpose solution, as specified in protocol.
- Vision correctable to 20/30 (Snellen) or better in each eye at distance at Visit 1.
- Willing to follow the study procedures and visit schedule.
- Other protocol-defined inclusion criteria may apply.
Read More
Exclusion Criteria
- Currently wearing Air Optix, Acuvue Oasys, or Acuvue Advance brand of lenses.
- Currently using any Opti-Free brand of multi-purpose solution.
- Must wear contact lenses on an extended wear (overnight) basis during the study.
- Known sensitivity or intolerance to POLYQUAD® or ALDOX preserved lens care products.
- Monocular (only one eye with functional vision), fit with only one lens, or monovision modality of wear.
- Use of additional lens care products other than a multi-purpose solution within 7 days prior to Visit 1.
- Use of topical ocular over-the-counter (OTC) or prescribed topical ocular medications, with the exception of contact lens rewetting drops, within 7 days prior to Visit 1.
- Any abnormal ocular condition observed during the Visit 1 slit-lamp examination.
- Current or history of ocular infections (i.e., microbial keratitis, conjunctivitis) or severe inflammation (i.e., iritis, infiltrates) within the 6 months prior to Visit 1.
- Ocular surgery within the 12 months prior to Visit 1.
- Any systemic diseases at Visit 1 (including allergies, respiratory infections or colds) that affect the eye and could be exacerbated by use of contact lenses or contact lens solutions.
- Participation in any clinical study within 30 days of Visit 1.
- Other protocol-defined exclusion criteria may apply.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Acuvue Oasys/Habitual MPS Habitual Multi-Purpose Solution (MPS) Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system Air Optix/OFPM OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS) Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system Air Optix/OFPM Lotrafilcon B contact lenses Lotrafilcon B contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with OPTI-FREE MPDS lens care system Acuvue Oasys/Habitual MPS Senofilcon A contact lenses Senofilcon A contact lenses (sphere, toric and multifocal), worn on a daily wear basis for 30 days, with habitual MPS lens care system
- Primary Outcome Measures
Name Time Method Likert Scale Questionnaire Item: "I Can Comfortably Wear my Lenses" Day 30; after 4 hours of lens wear Response of subject to a questionnaire item using a 5-point Likert scale, where 5=strongly agree and 1=strongly disagree.
- Secondary Outcome Measures
Name Time Method